Finance

Beta
Lists
PPLPHARMA:NSE
Piramal Pharma Ltd
₹173.49
+0.41%
(+0.70) 1D
Jun 1, 10:34:31 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for PPLPHARMA...
Open
₹172.99
High
₹173.89
Low
₹170.80
Mkt. cap
229.00B
Avg. vol.
7.29M
Volume
528.54K
Dividend
0.08%
Quarterly dividend
₹0.03
Ex-dividend date
Jul 16, 2025
52-wk high
₹220.85
52-wk low
₹132.30
EPS
-₹2.46
No. of employees
5K
Open
₹172.99
High
₹173.89
Low
₹170.80
Mkt. cap
229.00B
Avg. vol.
7.29M
Volume
528.54K
Dividend
0.08%
Quarterly dividend
₹0.03
Ex-dividend date
Jul 16, 2025
52-wk high
₹220.85
52-wk low
₹132.30
EPS
-₹2.46
No. of employees
5K
News stories
From sources across the web
About Piramal Pharma Ltd
CEOPeter DeYoung
Employees5.48K
Founded2020
Headquarters-
SectorPharmaceutical industry
Websitepiramalpharma.com
Last report
Apr 29, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹1.32 / ₹0.75
+77.14%beat
Revenue / Est. (INR)
27.52B / 26.75B
+2.88%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
19.34B
20.44B
21.40B
27.52B
Cost of goods sold
6.94B
7.02B
7.86B
10.56B
Cost of revenue
6.94B
7.02B
7.86B
10.56B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.19B
6.11B
6.00B
5.86B
Operating expense
13.30B
13.85B
13.71B
14.54B
Total operating expenses
20.24B
20.88B
21.57B
25.10B
Operating income
-905.80M
-441.50M
-170.10M
2.42B
Other non operating income
584.00M
656.00M
432.40M
460.60M
EBT including unusual items
-790.20M
-461.80M
-938.60M
430.10M
EBT excluding unusual items
-997.60M
-461.80M
-527.50M
2.19B
Income tax expense
26.80M
530.40M
423.30M
518.30M
Effective tax rate
-3.39%
-114.85%
-45.10%
120.51%
Other operating expenses
5.14B
5.71B
5.58B
6.50B
Net income
-817.00M
-992.20M
-1.36B
-88.20M
Net profit margin
-4.22%
-4.85%
-6.36%
-0.32%
Earnings per share
-0.78
-0.75
-0.72
1.32
Interest and investment income
-
-
-
-
Interest expense
-861.50M
-824.20M
-892.40M
-829.90M
Net interest expenses
-861.50M
-824.20M
-892.40M
-829.90M
Depreciation and amortization charges
1.97B
2.03B
2.13B
2.18B
EBITDA
941.02M
1.45B
1.68B
4.38B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer